4//SEC Filing
LINNIK MATTHEW D 4
Accession 0001209191-05-022463
CIK 0000920465other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 6:20 PM ET
Size
15.3 KB
Accession
0001209191-05-022463
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Award
Stock Option (right to buy)
2005-04-25$0.48/sh+72,765$34,927→ 859,934 totalExercise: $0.00Exp: 2015-04-25→ Common Stock (72,765 underlying) - Other
Common Stock
2005-03-31$0.59/sh+1,133$674→ 6,497 total - Gift
Stock Option (right to buy)
2005-04-26−787,169→ 72,765 totalExercise: $0.00→ Common Stock (787,169 underlying)
Footnotes (3)
- [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
- [F2]The stock options vest and become exercisable monthly over the next three years. In the event employee is terminated without cause or there is a change in control of the Company and employee's employment is terminated in connection with such change in control, the options automatically vest as of the date of employee's termination and remain exercisable for a period of one year following the date of termination.
- [F3]Shares transferred by reporting person to a trust of which the reporting person is a trustee.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237521
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 6:20 PM ET
- Size
- 15.3 KB